We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

NATR:NASDAQNature's Sunshine Products, Inc. Analysis

Data as of 2026-08-25 - not real-time

$14.19

Latest Price

9/10Risk

Risk Level: High

Executive Summary

Nature's Sunshine Products, Inc. trades at $14.19, with its short-term moving averages sitting below the longer-term ones — a bearish trend structure. It has lost 30.7% over the past 30 days. With RSI at 19.3 the momentum picture is oversold, alongside a bearish MACD signal. Watch $14.10 as support and $21.34 as the nearer resistance level.
Valuation screens as undervalued, on a P/E of 14.2 with no clean sector comparison available. The average analyst target implies 114.9% above today's level.
On a 1-10 scale the risk profile lands at 9 — high. With 30-day volatility of 68.8%, a beta of 0.42 and a maximum drawdown of 49.0%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
Short, medium and long-term reads agree on hold, with conviction of 2/10.

Top Market Events

Shares of wellness products company Nature’s Sunshine NASDAQ:NATR fell 17.What Happened? Shares of wellness products company Nature’s Sunshine NASDAQ:NATR fell 17.7% in the afternoon session...LEHI, Utah, Aug. 06, 2026 GLOBE NEWSWIRE -- Nature’s Sunshine Products, Inc. Nasdaq: NATR 'Nature’s Sunshine' , a...

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 1/10

Key Factors

  • Short-term moving averages stacked below long-term ones
  • RSI at 19.3 signals oversold conditions
  • Trading below the 200-day average of 22.48

Medium Term

1–3 years
Neutral
Model confidence: 1/10

Key Factors

  • Short-term moving averages stacked below long-term ones
  • RSI at 19.3 signals oversold conditions
  • Trading below the 200-day average of 22.48

Long Term

> 3 years
Neutral
Model confidence: 2/10

Key Factors

  • Analyst targets imply +114.9% versus the current price
  • P/E ratio of 14.2
  • 30-day volatility of 68.8%

Key Metrics & Analysis

Financial Health

Revenue Growth1.90%
Profit Margin3.68%
P/E Ratio14.2
ROE11.23%
ROA7.12%
Debt/Equity12.66
P/B Ratio1.5
Op. Cash Flow$27.4M
Free Cash Flow$16.5M

Technical Analysis

TrendBearish
RSI19.3
Support$14.10
Resistance$21.34
MA 20$16.91
MA 50$19.31
MA 200$22.48
MACDBearish
VolumeStable
Fear & Greed Index93.84

Valuation

Fair Value$16.48
Target Price$30.50
Upside/Downside114.94%
GradeUndervalued
TypeValue

Risk Assessment

Beta0.42
Volatility68.81%
Sector RiskLow
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.